Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 3, keine Gesamtzahl für „expected“
Suchtreffer
Begriffe & Kennungen
Dafiro HCT · 4.8 · In the 8-week controlled clinical study, no significant new or unexpected adverse reactions were observed with
Eintrag öffnenDarunavir Viatris (previously Darunavir Mylan) · 4.3 · Concomitant treatment with any of the following medicinal products given the expected decrease in plasma conce
Eintrag öffnenDelstrigo · 4.5 · Expected: doravirine Angiotensin converting enzyme inhibitors Interaction not studied with doravirine or dorav
Eintrag öffnenDelstrigo · 4.5 · Expected: doravirine Herbal supplements Interaction not studied with doravirine or doravirine/lamivudine/tenof
Eintrag öffnenDelstrigo · 4.5 · Expected: doravirine Interaction not studied with doravirine or doravirine/lamivudine/tenofovir daclatasvir di
Eintrag öffnenDelstrigo · 4.5 · Expected: doravirine Interaction not studied with doravirine or doravirine/lamivudine/tenofovir disoproxil. gl
Eintrag öffnenDelstrigo · 4.5 · Expected: doravirine Interaction not studied with doravirine or ombitasvir/paritaprevir/ doravirine/lamivudine
Eintrag öffnenDelstrigo · 4.5 · Expected: lisinopril Antiandrogens Interaction not studied with doravirine or doravirine/lamivudine/tenofovir
Eintrag öffnenDelstrigo · 4.5 · Expected: ↑ tenofovir Interaction not studied with Patients receiving doravirine or doravirine/lamivudine/teno
Eintrag öffnenDescovy · 4.5 · Co-administration of ciclosporin, a potent P-gp inhibitor, is expected to increase plasma concentrations of te
Eintrag öffnenDescovy · 4.5 · Co-administration of ciclosporin, a potent P-gp inhibitor, is expected to increase plasma concentrations of te
Eintrag öffnenDescovy · 4.5 · Co-administration of ketoconazole or itraconazole, which are potent P-gp inhibitors, is expected to increase p
Eintrag öffnenDescovy · 4.5 · Co-administration of ketoconazole or itraconazole, which are potent P-gp inhibitors, is expected to increase p
Eintrag öffnenDescovy · 4.5 · Tipranavir/ritonavir results in P-gp induction. Tenofovir alafenamide exposure is expected to decrease when ti
Eintrag öffnenDescovy · 4.5 · Tipranavir/ritonavir results in P-gp induction. Tenofovir alafenamide exposure is expected to decrease when ti
Eintrag öffnenDoptelet · 4.5 · The decrease in avatrombopag exposure is not expected to have a clinically important effect on platelet counts
Eintrag öffnenDoptelet · 4.5 · The increase in avatrombopag exposure is not expected to have a clinically important effect on platelet counts
Eintrag öffnenDuaklir Genuair · 4.5 · In vitro studies have shown that aclidinium or its metabolites at the therapeutic dose are not expected to cau
Eintrag öffnenDuoResp Spiromax · 4.5 · Co-treatment with CYP3A inhibitors, including cobicistat-containing products, is expected to increase the risk
Eintrag öffnenDuoResp Spiromax · 4.5 · Co-treatment with CYP3A inhibitors, including cobicistat-containing products, is expected to increase the risk
Eintrag öffnen